Neopharm, Inc.
Records under this name other than the patents Neopharm, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,442,520 | Gene BRCC-3 and Diagnostic and Therapeutic Uses Thereof Formerly held Term ended Term ended Dec 18, 2022 · Medium confidence | Term ended | Term ended Dec 18, 2022 | Medium confidence |
| US 8,809,541 | Heterocyclic compound, and composition for treating inflammatory diseases using same Lapsed on the fee record Ended Aug 19, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 19, 2022 | From the USPTO record |
| US 7,542,511 | Wireless RF link for uncompressed transmission of HDTV signals Lapsed on the fee record Ended Jun 2, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 2, 2021 | From the USPTO record |
| US 7,253,272 | Gene BRCC-2 and Diagnostic and Therapeutic Uses Thereof Formerly held Term ended Term ended May 14, 2021 · Medium confidence | Term ended | Term ended May 14, 2021 | Medium confidence |
| US 8,298,573 | Stable Sterile Filterable Liposomal Encapsulated Taxane and Other Antineoplastic Drugs Formerly held Lapsed on the fee record Ended Oct 30, 2020 · Medium confidence | Lapsed on the fee record | Ended Oct 30, 2020 | Medium confidence |
| US 6,461,637 | Method of administering liposomal encapsulated taxane Term ended Ended no later than Sep 1, 2020 · From the USPTO record | Term ended | Ended no later than Sep 1, 2020 | From the USPTO record |
| US 7,314,637 | Method of administering liposomal encapsulated taxane Term ended Ended no later than Jun 29, 2019 · From the USPTO record | Term ended | Ended no later than Jun 29, 2019 | From the USPTO record |
| US 6,221,371 | Pseudoceramides, and dermatologic external preparations containing the same Term ended Term ended May 10, 2019 · From the USPTO record | Term ended | Term ended May 10, 2019 | From the USPTO record |
| US 6,146,659 | Method of administering liposomal encapsulated taxane Term ended Term ended Jul 1, 2018 · From the USPTO record | Term ended | Term ended Jul 1, 2018 | From the USPTO record |
| US 7,462,739 | Ceramide derivatives, method for preparing the same, and therapeutic agent for treating atopic dermatitis comprising the ceramide derivatives Lapsed on the fee record Ended Dec 9, 2016 · From the USPTO record | Lapsed on the fee record | Ended Dec 9, 2016 | From the USPTO record |